Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Headlines > EU, Japan trust they have secured limits to US drug tariffs
    Headlines

    EU, Japan trust they have secured limits to US drug tariffs

    Published by Global Banking & Finance Review®

    Posted on September 26, 2025

    3 min read

    Last updated: January 21, 2026

    EU, Japan trust they have secured limits to US drug tariffs - Headlines news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:PresidentEuropean Commissionpharmaceutical market

    Quick Summary

    EU and Japan are confident in securing a 15% cap on US drug tariffs, countering Trump's 100% tariff threat. This impacts pharmaceutical trade significantly.

    EU and Japan Confident in Securing Limits on U.S. Drug Tariffs

    By Philip Blenkinsop

    BRUSSELS (Reuters) -The European Union and Japan expressed confidence on Friday that they had secured limits on U.S. tariffs on pharmaceuticals, which President Donald Trump said he would impose next week at a rate of 100%.

    The European Commission referred to a joint statement agreed with the U.S. following its end-July trade deal, which states that the tariff for pharmaceuticals, semiconductors and lumber would not exceed 15%.

    "This clear all-inclusive 15% tariff ceiling for EU exports represents an insurance policy that no higher tariffs will emerge for European economic operators," a Commission spokesperson said.

    CAUTIOUS OPTIMISM THAT CAP WILL APPLY

    European Trade Commissioner Maros Sefcovic, speaking in Hanoi, said he expected the commitment to be respected, noting that Washington had followed through in lowering car tariffs.

    Japan also referred to its joint statement with Washington, which said that U.S. tariff rates on Japanese semiconductors and pharmaceuticals would not exceed those applied to others such as the EU.

    A lobbyist for a major drugmaker with large European exports to the United States, said Trump's threat of 100% tariffs on branded drug imports was worrying, but the industry hoped the 15% rate agreed under the U.S.-EU trade deal would apply.

    "Nothing is clear yet but we hope the EU-U.S. deal stands," the lobbyist said.

    The EU's pharma lobby group, EFPIA, said it was working on the assumption that the EU-U.S. deal applied and that it was still pushing on exemptions for medicines.

    Europe and the U.S. have tightly linked medicine supply chains, with Ireland, Switzerland and Germany among top exporters.

    In a post on Truth Social on Thursday, Trump announced a fresh round of tariffs that also covered trucks at 25% and furniture at 30-50%.

    Trump said the pharmaceutical tariff of 100% would apply to branded or patented drugs unless a given pharmaceutical company was building a manufacturing plant in the United States.

    A source at a large European drugmaker said the company was quietly optimistic it would avoid 100% tariffs given the major U.S. investments it has pledged this year.

    Novo Nordisk CEO Mike Doustdar said on Friday it was uncertain how the 100% tariff decision aligned with the EU-U.S. trade deal. The Danish maker of weight-loss drug Wegovy and diabetes treatment Ozempic said it exported more active pharmaceutical ingredients from the U.S. than it imported.

    Swiss company Roche said on Friday one of its U.S. units has recently broken ground on a new facility.

    Swiss rival Novartis, which also made a large U.S. investment pledge earlier this year, did not immediately reply to a request for comment.

    An industry source estimated that, based on the initial U.S. indications, the tariffs as outlined by Trump on Thursday would probably not apply to the two Swiss companies.

    Drugmakers are also scrambling to cut cash prices for some U.S. drugs after Trump's demand that they do so ahead of a September 29 deadline, with tariffs threatened if he is not satisfied.

    (Reporting by Philip Blenkinsop. Additional reporting by Maggie Fick in London, Paul Arnold, Dave Graham in Zurich, Kantaro Komiya in Tokyo, Francesco Guarascio in Hanoiv. Editing by Gareth Jones and Mark Potter)

    Key Takeaways

    • •EU and Japan aim to limit US drug tariffs to 15%.
    • •Trump threatens 100% tariffs on pharmaceuticals.
    • •EU and Japan rely on joint statements with the US.
    • •Pharmaceutical industry seeks tariff exemptions.
    • •US investments may influence tariff decisions.

    Frequently Asked Questions about EU, Japan trust they have secured limits to US drug tariffs

    1What did the EU and Japan secure regarding U.S. tariffs?

    The EU and Japan expressed confidence that they had secured limits on U.S. tariffs on pharmaceuticals, with a tariff ceiling of 15% for EU exports.

    2What is the concern of the pharmaceutical industry regarding U.S. tariffs?

    The pharmaceutical industry is worried about President Trump's threat of 100% tariffs on branded drug imports but hopes the agreed 15% rate will be upheld.

    3How are U.S. tariffs expected to affect European drugmakers?

    European drugmakers are cautiously optimistic about avoiding the 100% tariffs, especially if they continue to invest in U.S. manufacturing.

    4What did Trump announce regarding tariffs on pharmaceuticals?

    Trump announced that a 100% tariff would apply to branded or patented drugs unless the pharmaceutical company builds a manufacturing plant in the U.S.

    5Which countries are mentioned as top exporters of pharmaceuticals to the U.S.?

    Ireland, Switzerland, and Germany are mentioned as top exporters of pharmaceuticals to the U.S.

    More from Headlines

    Explore more articles in the Headlines category

    Image for Hungary's opposition Tisza promises wealth tax, euro adoption in election programme
    Hungary's opposition Tisza promises wealth tax, euro adoption in election programme
    Image for Thousands protest in Berlin in solidarity with Iranian uprisings
    Thousands protest in Berlin in solidarity with Iranian uprisings
    Image for Farmers report 'catastrophic' damage to crops as Storm Marta hits Spain and Portugal
    Farmers report 'catastrophic' damage to crops as Storm Marta hits Spain and Portugal
    Image for France opens probe against ex-culture minister lang after Epstein file dump
    France opens probe against ex-culture minister lang after Epstein file dump
    Image for If US attacks, Iran says it will strike US bases in the region
    If US attacks, Iran says it will strike US bases in the region
    Image for Suspected saboteurs hit Italian rail network near Bologna, police say
    Suspected saboteurs hit Italian rail network near Bologna, police say
    Image for Olympics-Protesters in Milan denounce impact of Games on environment
    Olympics-Protesters in Milan denounce impact of Games on environment
    Image for Olympics-Biathlon-Winter Games bring tourism boost to biathlon hotbed of northern Italy
    Olympics-Biathlon-Winter Games bring tourism boost to biathlon hotbed of northern Italy
    Image for US pushes Russia and Ukraine to end war by summer, Zelenskiy says
    US pushes Russia and Ukraine to end war by summer, Zelenskiy says
    Image for Russia to interrogate two suspects over attempted killing of general, report says
    Russia to interrogate two suspects over attempted killing of general, report says
    Image for Russia launches massive attack on Ukraine's energy system, Zelenskiy says
    Russia launches massive attack on Ukraine's energy system, Zelenskiy says
    Image for Ukraine backs Pope's call for Olympic truce in war with Russia
    Ukraine backs Pope's call for Olympic truce in war with Russia
    View All Headlines Posts
    Previous Headlines PostMember of Irish rap group Kneecap has his UK terrorism prosecution thrown out
    Next Headlines PostSwiss government launches consultation on key UBS capital rule